Rain 47°
News
NJ Company's 223,000 Pounds Of Ready-To-Eat Salad Products Recalled NJ Company's 223,000 Pounds Of Ready-To-Eat Salad Products Recalled
NJ Company's 223,000 Pounds Of Ready-To-Eat Salad Products Recalled More than 200,000 pounds of pre-packaged salad products from a New Jersey company are being recalled due to misbranding and undeclared allergens. Ready Pac Foods East Coast establishments announced a recall of approximately 222,915 ready-to-eat salad products with meat and poultry because the products contain Food and Drug Administration (FDA) regulated salad dressing that has been recalled by the producer, Litehouse Inc., due to misbranding and an undeclared allergen that could impact some consumers. According to the US Department of Agriculture’s Food Safety and Inspection Service (FSIS),…

SHARE

by Zak Failla
News
COVID-19: Moderna Seeks Full FDA Vaccine Approval COVID-19: Moderna Seeks Full FDA Vaccine Approval
Covid-19: Moderna Seeks Full FDA Vaccine Approval With six months having passed since Moderna began clinical trials for its COVID-19 vaccine, the pharmaceutical company is seeking full approval from the Food and Drug Administration. Moderna, which currently has emergency use authorization from the FDA to distribute its vaccine, reported in its latest trial data that it has proven 90 percent effective in preventing the symptoms of COVID-19, and 95 percent effective in the most severe cases of the virus. Currently, no COVID-19 vaccine is fully approved by the FDA, but three - Moderna, Pfizer, and the currently questionable Johnson & John…

SHARE

by Zak Failla
News
COVID-19: Here's When Moderna Booster Shot Will Be Available For Those Who Got Both Doses COVID-19: Here's When Moderna Booster Shot Will Be Available For Those Who Got Both Doses
Covid-19: Here's When Moderna Booster Shot Will Be Available For Those Who Got Both Doses Moderna is working on a booster shot for its two-dose COVID-19 vaccine that will be made available by the fall to help avoid another surge of new cases over the winter. CEO Stephane Bancel said on CNBC that the company “wants to make sure there are boost vaccines available in the fall so that we protect people as we go into the next fall and winter season in the U.S.” Last month, the National Institutes of Health began testing several versions of boosters from Moderna that could potentially be used to combat variants of COVID-19, including the South African strain that has flummoxed resear…

SHARE

by Zak Failla
News
COVID-19: New Study Reveals How Prevalent Blood Clots Are With Pfizer, Moderna Vaccines COVID-19: New Study Reveals How Prevalent Blood Clots Are With Pfizer, Moderna Vaccines
Covid-19: New Study Reveals How Prevalent Blood Clots Are With Pfizer, Moderna Vaccines The ratio of people who have suffered from blood clots after receiving the Moderna or Pfizer COVID-19 vaccine is approximately the same as those who receive the AstraZeneca vaccine, according to a new study. Oxford University researchers found that the number of people who receive blood clots after getting vaccinated is approximately the same for all three vaccines, with four in one million people experiencing cerebral venous thrombosis (CVT) after getting the Pfizer or Moderna vaccine, compared to five in one million people for the AstraZeneca vaccine. The new study comes in the wake of A…

SHARE

by Zak Failla
News
Pfizer Asks FDA To Approve Emergency Use Of COVID Vaccine In Kids 12-15 Pfizer Asks FDA To Approve Emergency Use Of COVID Vaccine In Kids 12-15
Pfizer Asks FDA To Approve Emergency Use Of COVID Vaccine In Kids 12-15 Pfizer and BioNTech on Friday asked the Food and Drug Administration to expand emergency use authorization of the COVID-19 vaccine to include children ages 12 to 15. The request comes following the Phase 3 trial in children ages 12 to 15, which demonstrated 100 percent efficacy and robust antibody response after vaccination. The companies plan to request similar rulings by other regulatory authorities worldwide in coming days. "The hope of starting to vaccinate this age group before the start of the next school year," CEO Albert Bourla previously said in a statement. According t…

SHARE

by Cecilia Levine
News
Rutgers Scientist Who Developed First COVID-19 Saliva Test Dies Suddenly, 51 Rutgers Scientist Who Developed First COVID-19 Saliva Test Dies Suddenly, 51
Rutgers Scientist Who Developed First Covid-19 Saliva Test Dies Suddenly, 51 Rutgers University research professor Andrew Brooks, who played an integral role in the development of the first approved COVID-19 saliva test, died suddenly over the weekend. Brooks died on Saturday, Jan. 23. He was 51 years old. Gov. Phil Murphy remembered Brooks, affectionately known as Andy, as an unsung hero of New Jersey. "You may remember that name," Murphy said during Monday's COVID-19 briefing. "Why? Because last year in the frenetic early days of the pandemic, he led development of the... so-called spit or saliva test.  "[It was] the first test to be put into use anywhere i…

SHARE

by Cecilia Levine
News
COVID-19: Pfizer Boasts Vaccine Candidate That's More Than 90% Effective COVID-19: Pfizer Boasts Vaccine Candidate That's More Than 90% Effective
Covid-19: Pfizer Boasts Vaccine Candidate That's More Than 90% Effective More reliable than the flu shot? Pfizer on Monday trumpeted a COVID-19 vaccine candidate as more than 90% effective – nearly three times better than the effectiveness of last season’s influenza vaccine. Pfizer said it hopes to have 50 million doses of the free vaccine ready by the end of this year and as many as 1.3 billion doses available next year to fight the deadly global pandemic. Two doses per person of BNT162b2 would be necessary, said the Manhattan-based drug maker, which teamed up with BioNTech of Germany to develop the booster. Pfizer plans to ask the federal Food and Drug Admini…

SHARE

by Jerry DeMarco
News
Breast Implant Cancer Risk Was Covered Up By Morris County Company, 6 Women Say In Suit Breast Implant Cancer Risk Was Covered Up By Morris County Company, 6 Women Say In Suit
Breast Implant Cancer Risk Was Covered Up By Morris County Company, 6 Women Say In Suit A Morris County-based manufacturer is being sued by six women saying the company failed to warn the public of increased cancer risk caused by the breast implants they had. Allergan plc's Biocell brand textured implant is linked to anaplastic large cell lymphoma -- a rare immune system cancer that the women who had them were not warned of, according to the suits filed in Morristown Superior Court. Some of the suits say Allergan, based in Madison, deliberately obstructed public knowledge by submitting a non-public annual status report to the FDA.  More than 80 percent of known cases of …

SHARE

by Cecilia Levine